Gelonghui May 8 丨 Shengxiang Biotech (688289freshdeckpoker.SH) announced that it plans to jointly invest in the joint venture Hunan ShengweiSumin Biotechnology Co., Ltd.(referred to as "Hunan ShengweiSumin") with the related party Hunan Xiangjiang Shengxiang Biological Industry Fund Partnership (Limited Partnership), of which the company's total investment amount is RMB 53.33 million. At the same time, the company plans to invest in FirstLight Diagnostics,Inc. (abbreviated as "FirstLight") 21.69%freshdeckpokerThe equity of the company was transferred to a wholly-owned subsidiary of the joint venture company at a transfer consideration of US$2,215,835. In the future, we will rely on the joint venture company as an overall operation to further focus on the field of rapid drug sensitivity testing and accelerate the promotion of industrial research, application development and commercial transformation.